Silk Therapeutics Secures Financing

Silk Therapeutics has announced that the company has closed $3 million in Series A1 financing, exceeding the Series A1 funding goal by fifty percent. The company has raised a total of $4.25 million in Series A and Series A1 rounds.

The Series A1 round was led by The Kraft Group of Foxboro, Massachusetts, with participation by Sheri and Roy P. Disney; Richard Sackler, MD, with Summer Road, the Richard Sackler Family’s New York investment office; Erin Donohue and Ron Bresler, BML Group; and Altman Health Investments.

Silk Therapeutics has also welcomed Sheri Disney, a founder of the Sheri and Roy P. Disney Center for Integrative Medicine at Providence St. Joseph Medical Center, to its
Board of Directors; and Erin Donohue, a former executive at Louis Vuitton North America, Givenchy Canada and Four Seasons Hotels and Resorts, is joining the Company’s Strategic Advisory Board.

Gregory Altman, PhD, Chief Executive Office and co-Founder of Silk Therapeutics, said, “The successful closing of our round of financing demonstrates our investors’ interests in pure and powerful skincare in the anti-aging and skin health market segments, as well as the potential of our proprietary liquid silk technology in multiple dermatology, medical, textile and consumer markets.”

Silk Therapeutics will soon launch an ultrasensitive skincare treatment line, which are products designed as a pure and safe option for those with extremely sensitive skin, and certain skin conditions.

The brand’s packaging looks luxurious – airless bottles have silver actuators and overcaps; and the jars in the line have a metallic finish.